Melatonin Improves Endoplasmic Reticulum Stress-Mediated IRE1α Pathway in Zücker Diabetic Fatty Rat

Samira Aouichat1,2, Miguel Navarro-Alarcon3, Pablo Alarcón-Guijo1

  • 1Department of Pharmacology, Biohealth Institute and Neurosciences Institute, School of Medicine, University of Granada, 18016 Granada, Spain.

Insights

Melatonin, a natural compound, protects kidneys in diabetic rats by reducing endoplasmic reticulum (ER) stress and apoptosis. This study shows melatonin alleviates ER stress markers and improves kidney structure in diabetic conditions.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Obesity and diabetes significantly increase kidney disease prevalence.
  • Endoplasmic reticulum (ER) stress is a key factor in diabetes-related kidney disease pathogenesis.
  • Melatonin, an anti-obesogenic compound, previously showed renoprotective effects by restoring mitochondrial balance.

Purpose of the Study:

  • To investigate if melatonin suppresses renal ER stress and unfolded protein response in obese, diabetic rats.
  • To explore melatonin's impact on ER stress markers and apoptotic pathways in diabetic kidney injury.

Main Methods:

  • Zücker diabetic fatty (ZDF) and lean (ZL) rats were supplemented with melatonin or vehicle for 17 weeks.
  • Western blot analysis assessed ER stress markers (GRP78, IRE1α, ATF6, PERK) and apoptotic proteins (JNK, Bax, cleaved caspase-3, Bcl-2).
  • Renal morphology was evaluated to assess structural changes.

Main Results:

  • Diabetic ZDF rats exhibited higher ER stress and impaired renal morphology compared to lean ZL rats.
  • Melatonin treatment reduced ER stress markers (GRP78, IRE1α, ATF6) and ER stress-mediated apoptosis (decreased JNK, Bax, cleaved caspase-3; increased Bcl-2) in ZDF rats.
  • Melatonin supplementation led to renal structural recovery in ZDF rats.

Conclusions:

  • Melatonin demonstrates a renoprotective role in diabetic kidney injury.
  • Melatonin alleviates renal ER stress and inhibits the IRE1α/JNK apoptotic pathway.
  • These findings suggest melatonin as a potential therapeutic agent for diabetic nephropathy.

Related Concept Videos